Flagship Pioneering, LLC — 13F Holdings

2026 Q2  ·  5 Positions

2026 Q2 Portfolio Activity

In 2026 Q2, Flagship Pioneering, LLC maintained a portfolio of 5 distinct positions.
Position History hover any row below to update
Loading…
Flagship Pioneering, LLC Cambridge, MA Venture Capital / Life Sciences Investment Firm AUM $1,540M
PCA Score Concentration Risk
Risk ENB
Total Positions
5
Quarter
2026 Q2
Top Holding
N/A (68.7%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5

Flagship Pioneering, LLC Full Holdings List — 2026 Q2

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
N/A
GENERATE BIOMED...
Unknown 68.66% 67.44% #1
Prev: #1
7.0
no change no change
P
S
62,673,117 $1,057,295,483 13F Filing 2026-06-30 2026-08-14
MRNA
MODERNA INC
Healthcare 21.07% 20.26% #2
Prev: #2
6.5
no change no change
P
S
4,632,149 $324,389,395 2018 Q4 13F Filing 2026-06-30 2026-08-14
SANA
SANA BIOTECHNOL...
Healthcare 5.67% 6.20% #3
Prev: #3
4.3
no change no change
P
S
25,001,856 $87,256,477 2021 Q1 13F Filing 2026-06-30 2026-08-14
FHTX
FOGHORN THERAPE...
Healthcare 4.02% 5.22% #4
Prev: #4
3.1
no change no change
P
S
12,674,120 $61,849,706 2020 Q4 13F Filing 2026-06-30 2026-08-14
MCRB
SERES THERAPEUT...
Healthcare 0.59% 0.88% #5
Prev: #5
1.7
no change no change
P
S
1,155,850 $9,119,658 2025 Q2 13F Filing 2026-06-30 2026-08-14
Showing 1-5 of 5 holdings

Unlock Full Flagship Pioneering, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →